Jump Financial, LLC Verrica Pharmaceuticals Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	SELL	$3.75 - $7.46 $43,908 - $87,349	-11,709 Reduced 39.15%	18,200 $70,000
Q3 2023 Nov 07, 2023	BUY	$3.75 - $7.46 $68,250 - $135,772	18,200 New	18,200 $70,000
Q1 2023 Oct 21, 2024	BUY	$2.88 - $8.51 $86,137 - $254,525	29,909 New	29,909 $194,000
Q1 2023 May 03, 2023	BUY	$2.88 - $8.51 $86,137 - $254,525	29,909 New	29,909 $194,000
Q3 2021 Nov 12, 2021	SELL	$9.55 - $13.96 $157,326 - $229,977	-16,474 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$9.77 - $15.33 $160,950 - $252,546	16,474 New	16,474 $186,000

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.